Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1367 |
|
| Actual shortage: | 56 (4%) | |
| Anticipated shortage: | 6 (0%) | |
| Avoided shortage: | 37 (3%) | |
| Resolved: | 1268 (93%) | |
Discontinuation Reports |
291 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 287 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
211 (13%) |
|
Overdue reports |
8 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2018-02-06 | 2018-04-19 | 38857 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-02-12 | 2018-03-07 | 39510 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-04-20 | 2018-07-13 | 46689 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2018-05-04 | 2018-08-24 | 48514 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2018-08-24 | 2019-02-08 | 59107 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63047 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2018-10-03 | 2019-02-08 | 63054 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2018-11-28 | 2019-02-08 | 67863 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2019-03-04 | 2019-06-11 | 77450 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-03-29 | 2019-06-11 | 79847 |
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98802 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2021-07-29 | 2021-08-30 | 143172 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-14 | 2023-08-17 | 189598 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2024-03-15 | 2024-07-10 | 222369 |
| PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-03-24 | 2017-04-07 | 4171 |
| PMS-CANDESARTAN-HCTZ | 12.5MG 16.0MG | TABLET | Resolved | 2017-07-25 | 2018-01-26 | 17024 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |
| PMS-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117894 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |
| PMSC-METFORMIN | 500MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248798 |
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |